GlaxoSmithKline’s FDA approval for Cervarix, received last week as rival Merck expanded its Gardasil label, heralds a market-share battle that may hinge on science. Cervarix is approved to protect ...

GlaxoSmithKline said this week it was in discussions with the FDA about itsCervarix cervical cancer vaccine and hoped to issue soon an update onsubmitting the drug for approval, Reuters reported.

Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types Results also show significant additional ...

WASHINGTON – Federal health officials said Wednesday a long-delayed vaccine from GlaxoSmithKline successfully blocks the leading virus that causes cervical cancer in women. The Food and Drug ...

GlaxoSmithKline has published new data on its cervical cancer vaccine Cervarix which the firm says generated a significantly higher immune response than Merck & Co's rival product Gardasil, a claim ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. The Centers for Disease Control and Prevention’s Advisory Committee on ...

WASHINGTON (Reuters) - GlaxoSmithKline Plc's bid to sell its Cervarix cervical cancer vaccine in the United States faced further delay on Tuesday and the company recalled a batch of the vaccine in ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. For the record: An earlier version of this story and its headline ...

NEW YORK (Reuters) - GlaxoSmithKline Plc's cervical cancer vaccine Cervarix should eventually secure a 50 percent market share, despite being second to market, the group's chief executive said on ...

It seems that GlaxoSmithKline’s Cervarix is in the clear after a coroner concluded that the cervical cancer jab was unlikely to have played any part in the death of fourteen year-old Natalie Morton ...

September 30, 2009 (updated October 1, 2009) — The sudden death of a 14-year-old British girl shortly after she received Cervarix, a vaccine against human papillomavirus (HPV) to prevent cervical ...